{"id":9062,"date":"2020-06-24T09:15:00","date_gmt":"2020-06-24T07:15:00","guid":{"rendered":"https:\/\/irlab.se\/mfn_news\/irlabs-mesdopetam-presenteras-pa-omslaget-av-topprankade-vetenskapliga-tidskriften-jpet\/"},"modified":"2020-06-24T09:15:00","modified_gmt":"2020-06-24T07:15:00","slug":"irlabs-mesdopetam-presenteras-pa-omslaget-av-topprankade-vetenskapliga-tidskriften-jpet","status":"publish","type":"mfn_news","link":"https:\/\/irlab.se\/sv\/mfn_news\/irlabs-mesdopetam-presenteras-pa-omslaget-av-topprankade-vetenskapliga-tidskriften-jpet\/","title":{"rendered":"IRLABs mesdopetam presenteras p\u00e5 omslaget av topprankade vetenskapliga tidskriften JPET"},"content":{"rendered":"<p>[mfn_before_post]<\/p>\n<div class=\"mfn-preamble\"><strong>IRLAB meddelade idag att den h\u00f6gt rankade tidskriften JPET presenterar IRLABs l\u00e4kemedelskandidat mesdopetam (IRL790) p\u00e5 omslaget av senaste numret, 1 juli 2020. P\u00e5 omslaget illustreras hur mesdopetam binder till dopamin D3-receptorn. I den vetenskapliga artikeln beskrivs \u00e4ven l\u00e4kemedelskandidatens gynnsamma effekter p\u00e5 systemniv\u00e5 i hj\u00e4rnan. Mesdopetam utvecklas f\u00f6r behandling av motoriska och psykiatriska symtom vid Parkinsons sjukdom.<\/strong><\/div>\n<p><span><span><span><span><span>\u201dVi \u00e4r stolta \u00f6ver att IRLAB genom sin systembiologiska forskningsstrategi, ISP, uppt\u00e4ckt och utvecklat en unik l\u00e4kemedelskandidat som nu lyfts fram p\u00e5 omslaget av en av de mer prestigefyllda vetenskapliga tidskrifterna inom omr\u00e5det\u201d, s\u00e4ger Nicholas Waters, VD p\u00e5 IRLAB. \u201dDet \u00e4r mycket gl\u00e4djande att IRLAB f\u00e5r detta erk\u00e4nnande&#34;.<\/span><\/span><\/span><\/span><\/span><\/p>\n<p><span><span><em><span><span><span><span>JPET, The Journal of Pharmacology and Experimental Therapeutics, <\/span><\/span><\/span><\/span><\/em><span><span><span><span>\u00e4r en h\u00f6gt rankad internationell tidskrift inom forskning kring farmakologi. <\/span><\/span><\/span><\/span><span><span><span><span>Tidskriften \u00e4r utgiven av The American Society for Pharmacology and Experimental Therapeutics.<\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n<p><span><span><span><span><span>I ett tidigare pressmeddelande meddelades att denna vetenskapliga artikel publicerades online som en del av <em>JPET Fast Forward<\/em>, vilken inneh\u00e5ller artiklar i manuskriptform som har accepterats och publicerats i <em>JPET<\/em>.<\/span><\/span><\/span><\/span><\/span><\/p>\n<p><span><span><span><span><span><span>Artikeln: Waters,\u00a0S. <em>et al.<\/em> <\/span><\/span><\/span><\/span><span><span><span><span>Preclinical pharmacology of [2-(3-fluoro-5-methanesulfonylphenoxy)ethyl](propyl)amine (IRL790), a novel dopamine transmission modulator for the treatment of motor and psychiatric complications in Parkinson\u2019s disease. <em>Journal of Pharmacology and Experimental Therapeutics<\/em>, DOI:\u00a0<\/span><\/span><\/span><\/span><a href=\"https:\/\/doi.org\/10.1124\/jpet.119.264226\" rel=\"nofollow\"><span><span><span>https:\/\/doi.org\/10.1124\/jpet.119.264226<\/span><\/span><\/span><\/a><\/span><\/span><\/p>\n<div class=\"mfn-footer\">\n<p><strong>F\u00f6r vidare information<\/strong><\/p>\n<p>Nicholas Waters, VD\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<br \/>Tel: +46 730 75 77 01\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0 \u00a0\u00a0<br \/>E-post: <a href=\"mailto:nicholas.waters@irlab.se\" rel=\"nofollow\">nicholas.waters@irlab.se<\/a><\/p>\n<\/div>\n<div class=\"mfn-footer mfn-about\">\n<p><span><span><span><strong><span><span><span><span><span>Om IRLAB<\/span><\/span><\/span><\/span><\/span><\/strong><\/span><\/span><\/span><\/p>\n<p><span><span><span><span><span><span><span><span>IRLAB \u00e4r ett <\/span><\/span><\/span><\/span><\/span><span><span><span><span>svenskt forsknings- och l\u00e4kemedelsutvecklingsbolag som fokuserar p\u00e5 att utveckla nya l\u00e4kemedel f\u00f6r behandling vid Parkinsons sjukdom. Bolagets l\u00e4ngst framskridna l\u00e4kemedelskandidater, mesdopetam (IRL790) och IRL752, vilka b\u00e5da genomg\u00e5tt Fas IIa-studier, \u00e4r avsedda f\u00f6r behandling av n\u00e5gra av de sv\u00e5raste symtomen relaterade till Parkinsons sjukdom: ofrivilliga r\u00f6relser (PD-LIDs), psykos (PD-P) och symtom som \u00e4r kopplade till kognitiv f\u00f6rs\u00e4mring s\u00e5som f\u00f6rs\u00e4mrad balans och \u00f6kad risk f\u00f6r fall (PD-Fall). <\/span><\/span><\/span><\/span><span><span><span><span><span>Genom den egenutvecklade forskningsplattformen ISP (Integrative Screening Process) uppt\u00e4cker och utvecklar IRLAB l\u00e4kemedelskandidater f\u00f6r sjukdomar relaterade till det centrala nervsystemet (CNS) d\u00e4r stora v\u00e4xande medicinska behov f\u00f6religger. F\u00f6rutom de kliniska kandidaterna har ISP-plattformen dessutom genererat flera CNS-program som nu \u00e4r i preklinisk fas. <\/span><\/span><\/span><\/span><\/span><span><span><span><span><span>IRLAB:s Certified Adviser p\u00e5 Nasdaq First North Premier Growth Market \u00e4r FNCA Sweden AB, info@fnca.se, 08-528 00 399. <\/span><\/span><\/span><\/span><\/span><span><span><span><span><span>Mer information p\u00e5 <\/span><\/span><\/span><\/span><\/span><a href=\"http:\/\/www.irlab.se\" rel=\"nofollow\"><span><span><span><span>www.irlab.se<\/span><\/span><\/span><\/span><\/a><span><span><span><span><span>.<\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n<\/div>\n<p>[mfn_after_post]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>IRLAB meddelade idag att den h\u00f6gt rankade tidskriften JPET presenterar IRLABs l\u00e4kemedelskandidat mesdopetam (IRL790) p\u00e5 omslaget av senaste numret, 1 juli 2020. P\u00e5 omslaget illustreras hur mesdopetam binder till dopamin D3-receptorn. I den vetenskapliga artikeln beskrivs \u00e4ven l\u00e4kemedelskandidatens gynnsamma effekter p\u00e5 systemniv\u00e5 i hj\u00e4rnan. Mesdopetam utvecklas f\u00f6r behandling av motoriska och psykiatriska symtom vid Parkinsons sjukdom.<\/p>\n","protected":false},"template":"","class_list":["post-9062","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn-ci_sv","mfn-news-tag-mfn-type-ir_sv","mfn-news-tag-mfn_sv","mfn-news-tag-mfn-ci-other_sv","mfn-news-tag-mfn-lang-sv_sv"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.7 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>IRLABs mesdopetam presenteras p\u00e5 omslaget av topprankade vetenskapliga tidskriften JPET - IRLAB<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/irlab.se\/mfn_news\/irlabs-mesdopetam-presenteras-pa-omslaget-av-topprankade-vetenskapliga-tidskriften-jpet\/\" \/>\n<meta property=\"og:locale\" content=\"sv_SE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"IRLABs mesdopetam presenteras p\u00e5 omslaget av topprankade vetenskapliga tidskriften JPET - IRLAB\" \/>\n<meta property=\"og:description\" content=\"IRLAB meddelade idag att den h\u00f6gt rankade tidskriften JPET presenterar IRLABs l\u00e4kemedelskandidat mesdopetam (IRL790) p\u00e5 omslaget av senaste numret, 1 juli 2020. P\u00e5 omslaget illustreras hur mesdopetam binder till dopamin D3-receptorn. I den vetenskapliga artikeln beskrivs \u00e4ven l\u00e4kemedelskandidatens gynnsamma effekter p\u00e5 systemniv\u00e5 i hj\u00e4rnan. Mesdopetam utvecklas f\u00f6r behandling av motoriska och psykiatriska symtom vid Parkinsons sjukdom.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/irlab.se\/mfn_news\/irlabs-mesdopetam-presenteras-pa-omslaget-av-topprankade-vetenskapliga-tidskriften-jpet\/\" \/>\n<meta property=\"og:site_name\" content=\"IRLAB\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Ber\u00e4knad l\u00e4stid\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minuter\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/irlab.se\/mfn_news\/irlabs-mesdopetam-presenteras-pa-omslaget-av-topprankade-vetenskapliga-tidskriften-jpet\/\",\"url\":\"https:\/\/irlab.se\/mfn_news\/irlabs-mesdopetam-presenteras-pa-omslaget-av-topprankade-vetenskapliga-tidskriften-jpet\/\",\"name\":\"IRLABs mesdopetam presenteras p\u00e5 omslaget av topprankade vetenskapliga tidskriften JPET - IRLAB\",\"isPartOf\":{\"@id\":\"https:\/\/irlab.se\/#website\"},\"datePublished\":\"2020-06-24T07:15:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/irlab.se\/mfn_news\/irlabs-mesdopetam-presenteras-pa-omslaget-av-topprankade-vetenskapliga-tidskriften-jpet\/#breadcrumb\"},\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/irlab.se\/mfn_news\/irlabs-mesdopetam-presenteras-pa-omslaget-av-topprankade-vetenskapliga-tidskriften-jpet\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/irlab.se\/mfn_news\/irlabs-mesdopetam-presenteras-pa-omslaget-av-topprankade-vetenskapliga-tidskriften-jpet\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/irlab.se\/sv\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MFN News Items\",\"item\":\"https:\/\/irlab.se\/sv\/pressmeddelanden\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"IRLABs mesdopetam presenteras p\u00e5 omslaget av topprankade vetenskapliga tidskriften JPET\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/irlab.se\/#website\",\"url\":\"https:\/\/irlab.se\/\",\"name\":\"Irlab\",\"description\":\"Novel treatments for Parkinson&#039;s disease\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/irlab.se\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sv-SE\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"IRLABs mesdopetam presenteras p\u00e5 omslaget av topprankade vetenskapliga tidskriften JPET - IRLAB","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/irlab.se\/mfn_news\/irlabs-mesdopetam-presenteras-pa-omslaget-av-topprankade-vetenskapliga-tidskriften-jpet\/","og_locale":"sv_SE","og_type":"article","og_title":"IRLABs mesdopetam presenteras p\u00e5 omslaget av topprankade vetenskapliga tidskriften JPET - IRLAB","og_description":"IRLAB meddelade idag att den h\u00f6gt rankade tidskriften JPET presenterar IRLABs l\u00e4kemedelskandidat mesdopetam (IRL790) p\u00e5 omslaget av senaste numret, 1 juli 2020. P\u00e5 omslaget illustreras hur mesdopetam binder till dopamin D3-receptorn. I den vetenskapliga artikeln beskrivs \u00e4ven l\u00e4kemedelskandidatens gynnsamma effekter p\u00e5 systemniv\u00e5 i hj\u00e4rnan. Mesdopetam utvecklas f\u00f6r behandling av motoriska och psykiatriska symtom vid Parkinsons sjukdom.","og_url":"https:\/\/irlab.se\/mfn_news\/irlabs-mesdopetam-presenteras-pa-omslaget-av-topprankade-vetenskapliga-tidskriften-jpet\/","og_site_name":"IRLAB","twitter_card":"summary_large_image","twitter_misc":{"Ber\u00e4knad l\u00e4stid":"2 minuter"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/irlab.se\/mfn_news\/irlabs-mesdopetam-presenteras-pa-omslaget-av-topprankade-vetenskapliga-tidskriften-jpet\/","url":"https:\/\/irlab.se\/mfn_news\/irlabs-mesdopetam-presenteras-pa-omslaget-av-topprankade-vetenskapliga-tidskriften-jpet\/","name":"IRLABs mesdopetam presenteras p\u00e5 omslaget av topprankade vetenskapliga tidskriften JPET - IRLAB","isPartOf":{"@id":"https:\/\/irlab.se\/#website"},"datePublished":"2020-06-24T07:15:00+00:00","breadcrumb":{"@id":"https:\/\/irlab.se\/mfn_news\/irlabs-mesdopetam-presenteras-pa-omslaget-av-topprankade-vetenskapliga-tidskriften-jpet\/#breadcrumb"},"inLanguage":"sv-SE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/irlab.se\/mfn_news\/irlabs-mesdopetam-presenteras-pa-omslaget-av-topprankade-vetenskapliga-tidskriften-jpet\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/irlab.se\/mfn_news\/irlabs-mesdopetam-presenteras-pa-omslaget-av-topprankade-vetenskapliga-tidskriften-jpet\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/irlab.se\/sv\/"},{"@type":"ListItem","position":2,"name":"MFN News Items","item":"https:\/\/irlab.se\/sv\/pressmeddelanden\/"},{"@type":"ListItem","position":3,"name":"IRLABs mesdopetam presenteras p\u00e5 omslaget av topprankade vetenskapliga tidskriften JPET"}]},{"@type":"WebSite","@id":"https:\/\/irlab.se\/#website","url":"https:\/\/irlab.se\/","name":"Irlab","description":"Novel treatments for Parkinson&#039;s disease","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/irlab.se\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sv-SE"}]}},"_links":{"self":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/mfn_news\/9062","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/media?parent=9062"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}